Review article: The management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 4, 2014, Pages 354-362

  Patwardhan, V R ^a   Cardenas, A ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESTROGEN; NADOLOL; OCTREOTIDE; OMEPRAZOLE; PLACEBO; PROGESTERONE; PROPRANOLOL; SEROTONIN ANTAGONIST; SOMATOSTATIN; TERLIPRESSIN; THALIDOMIDE; VASOPRESSIN;

ARGON PLASMA COAGULATION; ASYMPTOMATIC DISEASE; CRYOTHERAPY; DRUG DOSE TITRATION; ESOPHAGUS VARICES BLEEDING; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LASER COAGULATION; LIVER CIRRHOSIS; NEODYMIUM YAG LASER; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL HYPERTENSIVE GASTROPATHY; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; STOMACH ANTRUM RESECTION; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH DISEASE; THERMOCOAGULATION; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

BIOPSY; ENDOSCOPY, GASTROINTESTINAL; GASTRIC ANTRAL VASCULAR ECTASIA; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; PORTAL PRESSURE; STOMACH DISEASES; VENOUS PRESSURE;

EID: 84904465159     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12824     Document Type: Review

References (75)

1. Schlichting P, Christensen E, Fauerholdt L, Poulsen H, Juhl E, Tygstrup N,. Main causes of death in cirrhosis. Scand J Gastroenterol 1983; 18: 881-8.
2. Primignani M, Carpinelli L, Preatoni P, et al,. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 2000; 119: 181-7.
3. Merli M, Nicolini G, Angeloni S, Gentili F, Attili AF, Riggio O,. The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol 2004; 99: 1959-65.
4. D'Amico G, Montalbano L, Traina M, et al,. Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology 1990; 99: 1558-64.
5. Ward EM, Raimondo M, Rosser BG, Wallace MB, Dickson RD,. Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation. J Clin Gastroenterol 2004; 38: 898-900.
6. Gostout CJ, Viggiano TR, Balm RK,. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol 1993; 88: 2030-3.
7. Sarin SK, Misra SP, Singal A, Thorat V, Broor SL,. Evaluation of the incidence and significance of the "mosaic pattern" in patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Am J Gastroenterol 1988; 83: 1235-9.
8. Papazian A, Braillon A, Dupas JL, Sevenet F, Capron JP,. Portal hypertensive gastric mucosa: an endoscopic study. Gut 1986; 27: 1199-203.
9. Spahr L, Villeneuve JP, Dufresne MP, et al,. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999; 44: 739-42.
10. Vincent C, Pomier-Layrargues G, Dagenais M, et al,. Cure of gastric antral vascular ectasia by liver transplantation despite persistent portal hypertension: a clue for pathogenesis. Liver Transpl 2002; 8: 717-20.
11. Ripoll C, Garcia-Tsao G,. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis. Editrice Gastroenterologica Italiana 2011; 43: 345-51.
12. Kumar A, Mishra SR, Sharma P, Sharma BC, Sarin SK,. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics. J Clin Gastroenterol 2010; 44: 294-300.
13. Kim MY, Choi H, Baik SK, et al,. Portal hypertensive gastropathy: correlation with portal hypertension and prognosis in cirrhosis. Dig Dis Sci 2010; 55: 3561-7.
14. Merkel C, Schipilliti M, Bighin R, et al,. Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study. Dig Liver Dis 2003; 35: 269-74.
15. Curvêlo LA, Brabosa W, Rhor R, et al,. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach. J Gastroenterol Hepatol 2009; 24: 1541-6.
16. Hashizume M, Tanaka K, Inokuchi K,. Morphology of gastric microcirculation in cirrhosis. Hepatology 1983; 3: 1008-12.
17. Kaviani A, Ohta M, Itani R, Sander F, Tarnawski AS, Sarfeh IJ,. Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat. J Gastrointest Surg 1997; 1: 371-6.
18. Ohta M, Hashizume M, Higashi H, et al,. Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994; 20: 1432-6.
19. Quintero E, Piqué JM, Bombi JA, et al,. Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology 1987; 93: 1054-61.
20. Saperas E, Pérez-Ayuso RM, Poca E, Bordas JM, Gaya J, Piqué JM,. Increased gastric PGE2 biosynthesis in cirrhotic patients with gastric vascular ectasia. Am J Gastroenterol 1990; 85: 138-44.
21. Lowes JR, Rode J,. Neuroendocrine cell proliferations in gastric antral vascular ectasia. Gastroenterology 1989; 97: 207-12.
22. Charneau J, Petit R, Calès P, Dauver A, Boyer J,. Antral motility in patients with cirrhosis with or without gastric antral vascular ectasia. Gut 1995; 37: 488-92.
23. De Franchis R,. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-52.
24. Spina GP, Arcidiacono R, Bosch J, et al,. Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy. 19 September 1992; 1994, pp. 461-7.
25. Tanoue K, Hashizume M, Wada H, Ohta M, Kitano S, Sugimachi K,. Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study. Gastrointest Endosc 1992; 38: 582-5.
26. Jeon SR, Kim JO, Kim JB, et al,. Portal hypertensive enteropathy diagnosed by capsule endoscopy in cirrhotic patients: a nationwide multicenter study. Dig Dis Sci 2014; 59: 1036-41.
27. Matsushita Y, Narahara Y, Fujimori S, et al,. Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension. J Gastroenterol 2012; 48: 633-9.
28. Diaz-Sanchez A,. Portal hypertensive colopathy is associated with portal hypertension severity in cirrhotic patients. World J Gastroenterol 2009; 15: 4781.
29. Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA,. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 1984; 87: 1165-70.
30. Ito M, Uchida Y, Kamano S, Kawabata H, Nishioka M,. Clinical comparisons between two subsets of gastric antral vascular ectasia. Gastrointest Endosc 2001; 53: 764-70.
31. Dulai GS, Jensen DM, Kovacs TOG, Gralnek IM, Jutabha R,. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy 2004; 36: 68-72.
32. McCormack TT, Sims J, Eyre-Brook I, et al,. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985; 26: 1226-32.
33. Suit PF, Petras RE, Bauer TW, Petrini JL,. Gastric antral vascular ectasia. A histologic and morphometric study of "the watermelon stomach". Am J Surg Pathol 1987; 11: 750-7.
34. D'Amico G, García-Pagán JC, Luca A, Bosch J,. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006; 131: 1611-24.
35. Albillos A, Bañares R, González M, et al,. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol 2007; 102: 1116-26.
36. Villanueva C, Aracil C, Colomo A, et al,. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology 2009; 137: 119-28.
37. Cubillas R, Rockey DC,. Portal hypertensive gastropathy: a review. Liver Int 2010; 30: 1094-102.
38. Lo GH, Lai KH, Cheng JS, et al,. The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: a prospective, controlled trial. Gastrointest Endosc 2001; 53: 579-84.
39. Sarin SK, Shahi HM, Jain M, Jain AK, Issar SK, Murthy NS,. The natural history of portal hypertensive gastropathy: influence of variceal eradication. Am J Gastroenterol 2000; 95: 2888-93.
40. Pérez-Ayuso RM, Piqué JM, Bosch J, et al,. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991; 337: 1431-4.
41. Hosking SW, Kennedy HJ, Seddon I, Triger DR,. The role of propranolol in congestive gastropathy of portal hypertension. Hepatology 1987; 7: 437-41.
42. de Franchis R,. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-76.
43. Kouroumalis EA, Koutroubakis IE, Manousos ON,. Somatostatin for acute severe bleeding from portal hypertensive gastropathy. Eur J Gastroenterol Hepatol 1998; 10: 509-12.
44. Zhou Y, Qiao L, Wu J, Hu H, Xu C,. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. J Gastroenterol Hepatol 2002; 17: 973-9.
45. Bruha R, Marecek Z, Spicak J, et al,. Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding. Hepatogastroenterology 2002; 49: 1161-6.
46. Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA,. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118: 905-11.
47. Orloff MJ, Orloff MS, Orloff SL, Haynes KS,. Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt. Hepatology 1995; 21: 1011-7.
48. Helton WS, Maves R, Wicks K, Johansen K,. Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison. Arch Surg 2001; 136: 17-20.
49. Henderson JM, Boyer TD, Kutner MH, et al,. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006; 130: 1643-51.
50. Jacqueline GO, Leary MDM, Patrick S, Yachimski MDM,. MD LSF. Surgery in the patient with liver disease. Clin Liver Dis 2009; 13: 211-31.
51. Herrera S, Bordas JM, Llach J, et al,. The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest Endosc 2008; 68: 440-6.
52. Smith LA, Morris AJ, Stanley AJ,. The use of Hemospray in portal hypertensive bleeding; a case series. J Hepatol. European Association for the Study of the. Liver 2014; 60: 457-60.
53. Nardone G, Rocco A, Balzano T, Budillon G,. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999; 13: 1429-36.
54. Tran A, Villeneuve JP, Bilodeau M, et al,. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol 1999; 94: 2909-11.
55. Dunne KA, Hill J, Dillon JF,. Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide. Eur J Gastroenterol Hepatol 2006; 18: 455-6.
56. Soykan I, Toruner M, Idilman R, Ozden A,. Reversal of iron deficiency anemia in a patient with gastric antral vascular ectasia treated with cyproheptadine. J Clin Gastroenterol 2003; 36: 183-4.
57. Swanson E, Mahgoub A, Macdonald R, Shaukat A,. Medical and Endoscopic Therapies for Angiodysplasia and Gastric Antral Vascular Ectasia: a Systematic Review. Clin Gastroenterol Hepatol 2014; 12: 571-82.
58. Manner H, May A, Faerber M, Rabenstein T, Ell C,. Safety and efficacy of a new high power argon plasma coagulation system (hp-APC) in lesions of the upper gastrointestinal tract. Dig Liver Dis 2006; 38: 471-8.
59. Fuccio L, Zagari RM, Serrani M, et al,. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia-related bleeding in patients with liver cirrhosis. Digestion 2009; 79: 143-50.
60. Yusoff I, Brennan F, Ormonde D, Laurence B,. Argon plasma coagulation for treatment of watermelon stomach. Endoscopy 2002; 34: 407-10.
61. Roman S, Saurin JC, Dumortier J, Perreira A, Bernard G, Ponchon T,. Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy 2003; 35: 1024-8.
62. Sebastian S, McLoughlin R, Qasim A, O'Morain CA, Buckley MJ,. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results. Dig Liver Dis 2004; 36: 212-7.
63. Kwan V, Bourke MJ, Williams SJ, et al,. Argon Plasma Coagulation in the Management of Symptomatic Gastrointestinal Vascular Lesions: experience in 100 Consecutive Patients with Long-Term Follow-Up. Am J Gastroenterol 2006; 101: 58-63.
64. Sato T, Yamazaki K, Akaike J,. Endoscopic band ligation versus argon plasma coagulation for gastric antral vascular ectasia associated with liver diseases. Dig Endosc 2011; 24: 237-42.
65. Wells CD, Harrison ME, Gurudu SR, et al,. Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc 2008; 68: 231-6.
66. Keohane J, Berro W, Harewood GC, Murray FE, Patchett SE,. Band ligation of gastric antral vascular ectasia is a safe and effective endoscopic treatment. Dig Endosc 2012; 25: 392-6.
67. Prachayakul V, Aswakul P, Leelakusolvong S,. Massive gastric antral vascular ectasia successfully treated by endoscopic band ligation as the initial therapy. World J Gastrointest Endosc. 2013; 5: 135-7.
68. Gross SA, Al-Haddad M, Gill KRS, Schore AN, Wallace MB,. Endoscopic mucosal ablation for the treatment of gastric antral vascular ectasia with the HALO90 system: a pilot study. Gastrointest Endosc 2008; 67: 324-7.
69. McGorisk T, Krishnan K, Keefer L, Komanduri S,. Radiofrequency ablation for refractory gastric antral vascular ectasia (with video). Gastrointest Endosc 2013; 78: 584-8.
70. Kantsevoy SV, Cruz-Correa MR, Vaughn CA, Jagannath SB, Pasricha PJ, Kalloo AN,. Endoscopic cryotherapy for the treatment of bleeding mucosal vascular lesions of the GI tract: a pilot study. Gastrointest Endosc 2003; 57: 403-6.
71. Cho S, Zanati S, Yong E, et al,. Endoscopic cryotherapy for the management of gastric antral vascular ectasia. Gastrointest Endosc 2008; 68: 895-902.
72. Walia SS, Sachdeva A, Kim JJ, Portocarrero DJ, Lewis TD, Zhao YS,. Cyanoacrylate spray for treatment of difficult-to-control GI bleeding. Gastrointest Endosc 2013; 78: 536-9.
73. Katsinelos P, Chatzimavroudis G, Katsinelos T, et al,. Endoscopic mucosal resection for recurrent gastric antral vascular ectasia. Vasa 2008; 37: 289-92.
74. Mann NS, Rachut E,. Gastric antral vascular ectasia causing severe hypoalbuminemia and anemia cured by antrectomy. J Clin Gastroenterol 2002; 34: 284-6.
75. Sherman V, Klassen DR, Feldman LS, Jabbari M, Marcus V, Fried GM,. Laparoscopic antrectomy: a novel approach to treating watermelon stomach. J Am Coll Surg 2003; 197: 864-7.